×
0 0.00282485875706219 0.00282485875706219 -0.00282485875706199 0.0254237288135595 0.0720338983050849 0.053672316384181 0.066723163841808
Stockreport

Acorda Therapeutics craters 24% premarket as FDA rejects Parkinson's application [MarketWatch]

ACORDA THERAPEUTICS (ACOR)  More Company Research Source: MarketWatch
Last acorda therapeutics earnings: 8/2 06:00 am Check Earnings Report
US:NASDAQ Investor Relations: acorda.com/investors
PDF UPDATE: Acorda Therapeutics shares crater 26% premarket after FDA rejects application for Parkinson's treatment Acorda Therapeutics Inc. shares ACOR, +2.19% slid 26% premarket Tuesday, after the company said it has received a Refusal to File letter from the U.S. Food and Drug Administration regarding its new drug application for inbrija, an investigational treatment for symptoms of Parkinson's disease. The FDA said the NDA was not complete enough to permit a substantive review. Specifically, it questioned the date by which the manufacturing site would be ready for inspection, as well as the submission of the drug master production record. The company said it will seek a meeting with the FDA and that it believes the issues can be addressed. "We will work with the FDA as quickly as possible to address the open issues and to clarify the path to successfully re-file our application," Chief Executive Ron Cohen said in a statement. "We remain confident in INBRIJA's data package and its p [Read more]

IMPACT SNAPSHOT EVENT TIME: ACOR
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
ACOR alerts
from News Quantified
Opt-in for
ACOR alerts

from News Quantified
Opt-in for
ACOR alerts

from News Quantified